Viscosupplementation Market Analysis: Challenges, Growth Factors, and Future Outlook

The global Viscosupplementation Market is expected to grow to USD 3.52 billion by the end of 2025. By 2030, the market is projected to reach USD 5.26 billion, reflecting a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.

Download FREE Sample

North America remains the leading market for hyaluronic acid (HA) injections, largely driven by the high prevalence of knee osteoarthritis and the widespread adoption of viscosupplementation as a non-surgical treatment option. The region's advanced healthcare infrastructure, access to orthopedic specialists, and early diagnostic capabilities further support market growth.

A key strategy shaping the industry is the innovation in HA formulations. Advancements include the development of higher molecular weight HA for extended joint lubrication, cross-linked HA for increased durability, and combination therapies that integrate corticosteroids or platelet-rich plasma (PRP) to enhance pain relief and functional outcomes. These innovations are central to improving patient quality of life and expanding the use of viscosupplementation in clinical practice.